PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection.
J Am Coll Cardiol
; 81(3): 224-234, 2023 01 24.
Article
in En
| MEDLINE
| ID: mdl-36653090
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Proprotein Convertase 9
/
COVID-19
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Year:
2023
Type:
Article